Active Biotech AB - Interim report January - September 2017
November 09 2017 - 2:30AM
Third quarter in
brief
-
The company's application related to one of the
patent families in the SILC project was granted patent in the
US
-
Preclinical data for a SILC substance was
published in the scientific journal Cancer Immunology
Research
-
The process to divest the company's research
facility at Ideon in Lund has been initiated, for further comments
related to the company's liquidity situation see the section
"Outlook, including significant risks and uncertainties"
Events after the end of the
period
-
In October, Active Biotech's partner Teva
Pharmaceutical Industries Ltd presented new data concerning
laquinimod for the treatment of multiple sclerosis at the
ECTRIMS-ACTRIMS congress
-
The Board of directors has decided to initiate
negotiations with the trade unions related to the winding up of the
companies animal test facility
Financial
summary
SEK M |
July-Sept. |
Jan.-Sept. |
Full-year |
|
2017 |
2016 |
2017 |
2016 |
2016 |
|
|
|
|
|
|
Net
sales |
5.1 |
4.1 |
14.8 |
12.0 |
19.0 |
Operating
loss |
-6.5 |
-11.1 |
-44.2 |
-41.6 |
-55.1 |
Loss for
the period |
-8.4 |
-12.4 |
-48.6 |
-44.8 |
-59.6 |
Loss per
share, before and after dilution (SEK) |
-0.09 |
-0.14 |
-0.50 |
-0.50 |
-0.65 |
Cash and
cash equivalents (at the end of the period) |
|
|
35.6 |
39.9 |
77.7 |
For further
information, please contact:
Helén Tuvesson,
CEO
Tel: +46 (0)46-19 21 56
Hans Kolam, CFO
Tel: +46 (0)46 19 20 44
|
Active
Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund
Tel: +46 (0)46-19 20 00
|
The report is also available at
www.activebiotech.com.
Active Biotech AB - Interim report
January - September 2017
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Active Biotech via Globenewswire
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Sep 2023 to Sep 2024